person

Dongyu Kang, M.D.

DongYu Kang, M.D.
as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Central South University
Roles
Principal Investigator
Trial investigator
no

Trials led

2
Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome
NCT03271866—Unknown
A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder
NCT03379597—Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR
Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome
trial
A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder
trial